Boston City Wide Allergy Immunology Rounds 2022:
Approach to Evaluation and Management of Patients with HAE
Recurrent Angioedema Management and Novel Biomarkers
Wednesday, June 15, 2022
6:00 pm – 8:30 pm
Description:
This lecture series provides cutting edge updates on topics of clinical importance to local specialists in the fields of Allergy and Immunology as well as specialists in the field of Pulmonary Medicine, ENT and Dermatology from the local teaching hospitals in Boston as well as the surrounding communities. The audience also includes fellows in training in allergy and immunology, Pulmonary Medicine and ENT. By selecting speakers of national renown and addressing a spectrum of topics, this series is a major educational event in the monthly academic calendar in Boston.
Learning Objectives:
Approach to Evaluation and Management of Patients with HAE
Upon completion of this activity, participants will be able to:
- Review clinical symptoms and pathophysiology of bradykinin mediated angioedema.
- Discuss guideline-based care in the management of patients with hereditary angioedema.
- Discuss diagnostic challenges in patients presenting with recurrent angioedema but normal labs.
- Provide an update on developments in bradykinin mediated angioedema diagnostics.
Recurrent Angioedema Management and Novel Biomarkers
Upon completion of this activity, participants will be able to:
- Review clinical symptoms and pathophysiology of bradykinin mediated angioedema.
- Discuss guideline-based care in the management of patients with hereditary angioedema.
- Discuss diagnostic challenges in patients presenting with recurrent angioedema but normal labs.
- Provide an update on developments in bradykinin mediated angioedema diagnostics.
Target Audience:
This activity is intended for all academic and community based Allergist, Pulmonologist, ENT specialists and Dermatologist, fellows in training as well as registered nurses who work in the specialized fields of Medicine. It is targeted to the greater Boston and Eastern Massachusetts area.
Agenda:
Time | Topic | Speaker |
6:00 pm | *Fellow's Tutorial |
6:45 | **Break |
7:00 | Approach to Evaluation and Management of Patients with HAE | Aleena Banerji, MD |
7:30 | **Break |
7:45 | Recurrent Angioedema Management and Novel Biomarkers | Marc A. Riedl, MD |
8:15 | Q&A |
8:30 pm | Conclusion of Educational Activity |
*Fellow's Tutorial is not eligible for CME credit
**Before the educational activity, during breaks, and after the educational activity - you have the opportunity to view/meet with Virtual Exhibitors
Faculty:
Aleena Banerji, MD - Interim Course Director
Associate Professor of Medicine,
Harvard Medical School;
Clinical Director, Allergy and Clinical Immunology,
Director, Drug Allergy Program,
Division of Rheumatology, Allergy and Immunology
Massachusetts General Hospital
Marc A. Riedl, MD
Allergist/Immunologist,
Clinical Director, Angioedema Center,
Professor of Medicine
University of California, San Diego
Accreditation:
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provided By:
Massachusetts General Hospital and Mass General Brigham
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation